Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

ClinicalTrials.gov ID: NCT00920972

Public ClinicalTrials.gov record NCT00920972. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 1, 2026, 9:30 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease Using a Reduced-Intensity Preparatory Regime

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The hypothesis for this study is that a preparative regimen that maximizes host immunosuppression without myeloablation will be well tolerated and sufficient for engraftment of donor hematopoietic cells. It is also to determine major toxicities from these conditioning regimens, within the first 100 days after transplantation.

Study identification

NCT ID: NCT00920972
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: Washington University School of Medicine; Other
Enrollment: 220 participants

Conditions and interventions

Conditions

Interventions

Treatment Plan 1: Stratum 1 Drug
Treatment Plan 2: Strata 2, 3, or 4 Drug
GVHD Regimen A: UCB Recipients Drug
GVHD Regimen B: BM Recipients Drug

Drug

Eligibility (public fields only)

Age range: Up to 20 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 2001 (Actual)
Primary completion: Dec 2026 (Estimated)
Completion: Dec 2031 (Estimated)
Last update posted: Sep 16, 2026

2001 – 2031

United States locations

U.S. sites: 25
U.S. states: 16
U.S. cities: 23

Facility	City	State	ZIP	Site status
Phoenix Children's Hospital	Phoenix	Arizona	85016	Active, not recruiting
Children's Hospital of Orange County	Orange	California	92868	Active, not recruiting
University of California	San Diego	California	92123	Active, not recruiting
Yale School of Medicine	New Haven	Connecticut	06510	Active, not recruiting
George Washington University School of Medicine	Washington D.C.	District of Columbia	20010	Active, not recruiting
Nemours Children's Health	Jacksonville	Florida	32207	Completed
University of Miami	Miami	Florida	33136	Active, not recruiting
Miami Children's Hospital	Miami	Florida	33155	Completed
All Children's Hospital	St. Petersburg	Florida	33701	Completed
Children's Memorial Hospital	Chicago	Illinois	60614	Completed
Indiana University School of Medicine	Indianapolis	Indiana	46202	Active, not recruiting
Children's Hospital of New Orleans	New Orleans	Louisiana	70118	Completed
Children's Mercy	Kansas City	Missouri	64108	Completed
St. Louis University	St Louis	Missouri	63104	Active, not recruiting
Washington University School of Medicine (in St. Louis)	St Louis	Missouri	63110	Recruiting
Hackensack University Medical Center	Hackensack	New Jersey	07601	Completed
Columbia University Medical Center	New York	New York	10032	Active, not recruiting
University of North Carolina	Chapel Hill	North Carolina	27514	Active, not recruiting
Carolinas Medical Center	Charlotte	North Carolina	28232	Completed
Duke Children's Hospital	Durham	North Carolina	27705	Completed
The University of Oklahoma	Oklahoma City	Oklahoma	73104	Completed
University of Pittsburg	Pittsburgh	Pennsylvania	15224	Completed
Cook Children's Hospital	Forth Worth	Texas	76104	Completed
Texas Transplant Institute	San Antonio	Texas	78229	Completed
University of Utah	Salt Lake City	Utah	84132	Active, not recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00920972, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 16, 2026 · Synced Nov 1, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00920972 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →